nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—ALB—hepatitis B	0.708	1	CbGaD
Norethindrone—SHBG—semen—hepatitis B	0.0166	0.311	CbGeAlD
Norethindrone—SHBG—blood plasma—hepatitis B	0.00605	0.113	CbGeAlD
Norethindrone—Tenderness—Telbivudine—hepatitis B	0.00604	0.0281	CcSEcCtD
Norethindrone—Pregnancy—Lamivudine—hepatitis B	0.00523	0.0244	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Entecavir—hepatitis B	0.00481	0.0224	CcSEcCtD
Norethindrone—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00477	0.0222	CcSEcCtD
Norethindrone—Breast enlargement—Lamivudine—hepatitis B	0.00458	0.0213	CcSEcCtD
Norethindrone—Abdominal cramps—Lamivudine—hepatitis B	0.0044	0.0205	CcSEcCtD
Norethindrone—CYP2C19—blood plasma—hepatitis B	0.00402	0.0753	CbGeAlD
Norethindrone—Renal impairment—Telbivudine—hepatitis B	0.00402	0.0187	CcSEcCtD
Norethindrone—Pain in extremity—Telbivudine—hepatitis B	0.00382	0.0178	CcSEcCtD
Norethindrone—Migraine—Telbivudine—hepatitis B	0.00376	0.0175	CcSEcCtD
Norethindrone—Acne—Lamivudine—hepatitis B	0.00353	0.0164	CcSEcCtD
Norethindrone—Renal failure—Entecavir—hepatitis B	0.00353	0.0164	CcSEcCtD
Norethindrone—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00344	0.016	CcSEcCtD
Norethindrone—Hepatobiliary disease—Entecavir—hepatitis B	0.00339	0.0158	CcSEcCtD
Norethindrone—Abdominal distension—Telbivudine—hepatitis B	0.00333	0.0155	CcSEcCtD
Norethindrone—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00331	0.0154	CcSEcCtD
Norethindrone—Hepatitis—Entecavir—hepatitis B	0.00322	0.015	CcSEcCtD
Norethindrone—CYP3A5—blood plasma—hepatitis B	0.00317	0.0593	CbGeAlD
Norethindrone—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00314	0.0146	CcSEcCtD
Norethindrone—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00309	0.0144	CcSEcCtD
Norethindrone—Immune system disorder—Entecavir—hepatitis B	0.00291	0.0135	CcSEcCtD
Norethindrone—Renal failure—Telbivudine—hepatitis B	0.0029	0.0135	CcSEcCtD
Norethindrone—Alopecia—Entecavir—hepatitis B	0.00285	0.0133	CcSEcCtD
Norethindrone—Mental disorder—Entecavir—hepatitis B	0.00282	0.0131	CcSEcCtD
Norethindrone—Hepatobiliary disease—Telbivudine—hepatitis B	0.00279	0.013	CcSEcCtD
Norethindrone—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00269	0.0125	CcSEcCtD
Norethindrone—Hepatitis—Telbivudine—hepatitis B	0.00265	0.0123	CcSEcCtD
Norethindrone—Connective tissue disorder—Telbivudine—hepatitis B	0.0026	0.0121	CcSEcCtD
Norethindrone—CYP3A7—liver—hepatitis B	0.00258	0.0483	CbGeAlD
Norethindrone—CYP3A4—blood plasma—hepatitis B	0.00238	0.0445	CbGeAlD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00237	0.011	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00231	0.0108	CcSEcCtD
Norethindrone—Anaphylactic shock—Entecavir—hepatitis B	0.00229	0.0107	CcSEcCtD
Norethindrone—Renal impairment—Lamivudine—hepatitis B	0.00226	0.0105	CcSEcCtD
Norethindrone—Skin disorder—Entecavir—hepatitis B	0.00222	0.0103	CcSEcCtD
Norethindrone—SHBG—blood—hepatitis B	0.00222	0.0415	CbGeAlD
Norethindrone—CYP3A7-CYP3A51P—liver—hepatitis B	0.00219	0.0411	CbGeAlD
Norethindrone—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00217	0.0101	CcSEcCtD
Norethindrone—Affect lability—Lamivudine—hepatitis B	0.00212	0.00988	CcSEcCtD
Norethindrone—Migraine—Lamivudine—hepatitis B	0.00212	0.00988	CcSEcCtD
Norethindrone—Insomnia—Entecavir—hepatitis B	0.00207	0.00964	CcSEcCtD
Norethindrone—Mood swings—Lamivudine—hepatitis B	0.00204	0.00951	CcSEcCtD
Norethindrone—Somnolence—Entecavir—hepatitis B	0.00203	0.00947	CcSEcCtD
Norethindrone—Dyspepsia—Entecavir—hepatitis B	0.00201	0.00938	CcSEcCtD
Norethindrone—PGR—blood—hepatitis B	0.002	0.0374	CbGeAlD
Norethindrone—Gastrointestinal disorder—Entecavir—hepatitis B	0.00197	0.0092	CcSEcCtD
Norethindrone—Fatigue—Entecavir—hepatitis B	0.00197	0.00918	CcSEcCtD
Norethindrone—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00196	0.00915	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00195	0.00907	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00193	0.00897	CcSEcCtD
Norethindrone—Abdominal distension—Lamivudine—hepatitis B	0.00187	0.00873	CcSEcCtD
Norethindrone—Gastrointestinal pain—Entecavir—hepatitis B	0.00187	0.00871	CcSEcCtD
Norethindrone—Skin disorder—Telbivudine—hepatitis B	0.00183	0.0085	CcSEcCtD
Norethindrone—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00183	0.0085	CcSEcCtD
Norethindrone—Abdominal pain—Entecavir—hepatitis B	0.00181	0.00842	CcSEcCtD
Norethindrone—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00176	0.00822	CcSEcCtD
Norethindrone—SHBG—liver—hepatitis B	0.00173	0.0325	CbGeAlD
Norethindrone—Insomnia—Telbivudine—hepatitis B	0.0017	0.00792	CcSEcCtD
Norethindrone—ABCB1—blood plasma—hepatitis B	0.00168	0.0315	CbGeAlD
Norethindrone—Depression—Lamivudine—hepatitis B	0.00166	0.00771	CcSEcCtD
Norethindrone—Dyspepsia—Telbivudine—hepatitis B	0.00165	0.0077	CcSEcCtD
Norethindrone—Asthenia—Entecavir—hepatitis B	0.00164	0.00764	CcSEcCtD
Norethindrone—Renal failure—Lamivudine—hepatitis B	0.00163	0.0076	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00162	0.00756	CcSEcCtD
Norethindrone—Fatigue—Telbivudine—hepatitis B	0.00162	0.00754	CcSEcCtD
Norethindrone—Asthenia—Adefovir Dipivoxil—hepatitis B	0.0016	0.00746	CcSEcCtD
Norethindrone—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00158	0.00735	CcSEcCtD
Norethindrone—Hepatobiliary disease—Lamivudine—hepatitis B	0.00157	0.00731	CcSEcCtD
Norethindrone—Gastrointestinal pain—Telbivudine—hepatitis B	0.00154	0.00716	CcSEcCtD
Norethindrone—Dizziness—Entecavir—hepatitis B	0.00151	0.00704	CcSEcCtD
Norethindrone—Hepatitis—Lamivudine—hepatitis B	0.00149	0.00694	CcSEcCtD
Norethindrone—Abdominal pain—Telbivudine—hepatitis B	0.00149	0.00692	CcSEcCtD
Norethindrone—CYP2C19—blood—hepatitis B	0.00147	0.0276	CbGeAlD
Norethindrone—Connective tissue disorder—Lamivudine—hepatitis B	0.00146	0.00682	CcSEcCtD
Norethindrone—Vomiting—Entecavir—hepatitis B	0.00145	0.00677	CcSEcCtD
Norethindrone—Rash—Entecavir—hepatitis B	0.00144	0.00672	CcSEcCtD
Norethindrone—Dermatitis—Entecavir—hepatitis B	0.00144	0.00671	CcSEcCtD
Norethindrone—Headache—Entecavir—hepatitis B	0.00143	0.00667	CcSEcCtD
Norethindrone—ALB—liver—hepatitis B	0.00143	0.0268	CbGeAlD
Norethindrone—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00142	0.00661	CcSEcCtD
Norethindrone—Erythema multiforme—Lamivudine—hepatitis B	0.00141	0.00656	CcSEcCtD
Norethindrone—Rash—Adefovir Dipivoxil—hepatitis B	0.00141	0.00655	CcSEcCtD
Norethindrone—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00141	0.00655	CcSEcCtD
Norethindrone—Headache—Adefovir Dipivoxil—hepatitis B	0.0014	0.00651	CcSEcCtD
Norethindrone—Nausea—Entecavir—hepatitis B	0.00136	0.00633	CcSEcCtD
Norethindrone—Asthenia—Telbivudine—hepatitis B	0.00135	0.00628	CcSEcCtD
Norethindrone—Immune system disorder—Lamivudine—hepatitis B	0.00135	0.00627	CcSEcCtD
Norethindrone—Pruritus—Telbivudine—hepatitis B	0.00133	0.00619	CcSEcCtD
Norethindrone—Nausea—Adefovir Dipivoxil—hepatitis B	0.00133	0.00617	CcSEcCtD
Norethindrone—Alopecia—Lamivudine—hepatitis B	0.00132	0.00613	CcSEcCtD
Norethindrone—Flatulence—Lamivudine—hepatitis B	0.00128	0.00595	CcSEcCtD
Norethindrone—Tension—Lamivudine—hepatitis B	0.00127	0.00593	CcSEcCtD
Norethindrone—Nervousness—Lamivudine—hepatitis B	0.00126	0.00587	CcSEcCtD
Norethindrone—Dizziness—Telbivudine—hepatitis B	0.00124	0.00579	CcSEcCtD
Norethindrone—Vomiting—Telbivudine—hepatitis B	0.00119	0.00556	CcSEcCtD
Norethindrone—Rash—Telbivudine—hepatitis B	0.00118	0.00552	CcSEcCtD
Norethindrone—Dermatitis—Telbivudine—hepatitis B	0.00118	0.00551	CcSEcCtD
Norethindrone—Headache—Telbivudine—hepatitis B	0.00118	0.00548	CcSEcCtD
Norethindrone—CYP3A5—blood—hepatitis B	0.00116	0.0217	CbGeAlD
Norethindrone—CYP2C19—liver—hepatitis B	0.00115	0.0216	CbGeAlD
Norethindrone—Convulsion—Lamivudine—hepatitis B	0.00112	0.00524	CcSEcCtD
Norethindrone—Nausea—Telbivudine—hepatitis B	0.00112	0.0052	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.0011	0.00511	CcSEcCtD
Norethindrone—ALB—Scavenging of heme from plasma—HP—hepatitis B	0.00106	0.0444	CbGpPWpGaD
Norethindrone—Anaphylactic shock—Lamivudine—hepatitis B	0.00106	0.00493	CcSEcCtD
Norethindrone—Oedema—Lamivudine—hepatitis B	0.00106	0.00493	CcSEcCtD
Norethindrone—Skin disorder—Lamivudine—hepatitis B	0.00103	0.00479	CcSEcCtD
Norethindrone—PGR—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00097	0.0405	CbGpPWpGaD
Norethindrone—Insomnia—Lamivudine—hepatitis B	0.000958	0.00446	CcSEcCtD
Norethindrone—CYP3A5—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.000946	0.0395	CbGpPWpGaD
Norethindrone—Somnolence—Lamivudine—hepatitis B	0.000941	0.00438	CcSEcCtD
Norethindrone—Dyspepsia—Lamivudine—hepatitis B	0.000932	0.00434	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000914	0.00426	CcSEcCtD
Norethindrone—Fatigue—Lamivudine—hepatitis B	0.000913	0.00425	CcSEcCtD
Norethindrone—CYP3A5—liver—hepatitis B	0.000908	0.017	CbGeAlD
Norethindrone—CYP3A4—blood—hepatitis B	0.000871	0.0163	CbGeAlD
Norethindrone—Gastrointestinal pain—Lamivudine—hepatitis B	0.000866	0.00403	CcSEcCtD
Norethindrone—PGR—Nuclear Receptors—HNF4A—hepatitis B	0.000851	0.0356	CbGpPWpGaD
Norethindrone—Urticaria—Lamivudine—hepatitis B	0.000841	0.00392	CcSEcCtD
Norethindrone—Abdominal pain—Lamivudine—hepatitis B	0.000837	0.0039	CcSEcCtD
Norethindrone—PGR—Validated nuclear estrogen receptor alpha network—NR0B2—hepatitis B	0.000809	0.0338	CbGpPWpGaD
Norethindrone—PGR—Cellular roles of Anthrax toxin—IL18—hepatitis B	0.000801	0.0335	CbGpPWpGaD
Norethindrone—Hypersensitivity—Lamivudine—hepatitis B	0.00078	0.00363	CcSEcCtD
Norethindrone—CYP3A7—Xenobiotics—CYP2A6—hepatitis B	0.000761	0.0318	CbGpPWpGaD
Norethindrone—Asthenia—Lamivudine—hepatitis B	0.00076	0.00354	CcSEcCtD
Norethindrone—Pruritus—Lamivudine—hepatitis B	0.000749	0.00349	CcSEcCtD
Norethindrone—Dizziness—Lamivudine—hepatitis B	0.0007	0.00326	CcSEcCtD
Norethindrone—CYP2C19—CYP2E1 reactions—CYP2A6—hepatitis B	0.000686	0.0287	CbGpPWpGaD
Norethindrone—CYP3A4—liver—hepatitis B	0.000681	0.0128	CbGeAlD
Norethindrone—Vomiting—Lamivudine—hepatitis B	0.000673	0.00314	CcSEcCtD
Norethindrone—PGR—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.000672	0.0281	CbGpPWpGaD
Norethindrone—Rash—Lamivudine—hepatitis B	0.000668	0.00311	CcSEcCtD
Norethindrone—Dermatitis—Lamivudine—hepatitis B	0.000667	0.00311	CcSEcCtD
Norethindrone—Headache—Lamivudine—hepatitis B	0.000663	0.00309	CcSEcCtD
Norethindrone—Nausea—Lamivudine—hepatitis B	0.000629	0.00293	CcSEcCtD
Norethindrone—ABCB1—blood—hepatitis B	0.000617	0.0115	CbGeAlD
Norethindrone—CYP3A5—Xenobiotics—CYP2A6—hepatitis B	0.00055	0.023	CbGpPWpGaD
Norethindrone—CYP3A5—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000529	0.0221	CbGpPWpGaD
Norethindrone—ABCB1—liver—hepatitis B	0.000482	0.00903	CbGeAlD
Norethindrone—CYP3A5—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000447	0.0187	CbGpPWpGaD
Norethindrone—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00044	0.0184	CbGpPWpGaD
Norethindrone—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.000425	0.0178	CbGpPWpGaD
Norethindrone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HP—hepatitis B	0.000424	0.0177	CbGpPWpGaD
Norethindrone—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000409	0.0171	CbGpPWpGaD
Norethindrone—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.000409	0.0171	CbGpPWpGaD
Norethindrone—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000378	0.0158	CbGpPWpGaD
Norethindrone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000316	0.0132	CbGpPWpGaD
Norethindrone—CYP3A7—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000312	0.013	CbGpPWpGaD
Norethindrone—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.000306	0.0128	CbGpPWpGaD
Norethindrone—PGR—Cellular roles of Anthrax toxin—TNF—hepatitis B	0.000304	0.0127	CbGpPWpGaD
Norethindrone—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000292	0.0122	CbGpPWpGaD
Norethindrone—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000285	0.0119	CbGpPWpGaD
Norethindrone—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—hepatitis B	0.000268	0.0112	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.000263	0.011	CbGpPWpGaD
Norethindrone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000256	0.0107	CbGpPWpGaD
Norethindrone—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000256	0.0107	CbGpPWpGaD
Norethindrone—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000246	0.0103	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—GGT2—hepatitis B	0.000239	0.00999	CbGpPWpGaD
Norethindrone—CYP3A7—Metapathway biotransformation—AKR1B1—hepatitis B	0.000231	0.00966	CbGpPWpGaD
Norethindrone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000228	0.00955	CbGpPWpGaD
Norethindrone—CYP3A5—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000225	0.00942	CbGpPWpGaD
Norethindrone—CYP3A7—Biological oxidations—GGT2—hepatitis B	0.000225	0.00939	CbGpPWpGaD
Norethindrone—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000208	0.00869	CbGpPWpGaD
Norethindrone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000185	0.00774	CbGpPWpGaD
Norethindrone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000177	0.00738	CbGpPWpGaD
Norethindrone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000176	0.00734	CbGpPWpGaD
Norethindrone—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000174	0.00728	CbGpPWpGaD
Norethindrone—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.00017	0.0071	CbGpPWpGaD
Norethindrone—PGR—Generic Transcription Pathway—NR0B2—hepatitis B	0.000168	0.007	CbGpPWpGaD
Norethindrone—CYP3A5—Metapathway biotransformation—AKR1B1—hepatitis B	0.000167	0.00698	CbGpPWpGaD
Norethindrone—CYP3A5—Biological oxidations—GGT2—hepatitis B	0.000162	0.00679	CbGpPWpGaD
Norethindrone—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.00016	0.00667	CbGpPWpGaD
Norethindrone—ALB—Platelet degranulation—HSPA5—hepatitis B	0.000145	0.00604	CbGpPWpGaD
Norethindrone—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000143	0.00598	CbGpPWpGaD
Norethindrone—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—hepatitis B	0.000138	0.00576	CbGpPWpGaD
Norethindrone—CYP3A7—Biological oxidations—CYP2A6—hepatitis B	0.000136	0.00569	CbGpPWpGaD
Norethindrone—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000129	0.0054	CbGpPWpGaD
Norethindrone—ALB—FOXA2 and FOXA3 transcription factor networks—F2—hepatitis B	0.000126	0.00527	CbGpPWpGaD
Norethindrone—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000126	0.00525	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000121	0.00505	CbGpPWpGaD
Norethindrone—PGR—Generic Transcription Pathway—HNF4A—hepatitis B	0.000116	0.00485	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—GGT1—hepatitis B	0.000113	0.00472	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—F2—hepatitis B	0.000112	0.00468	CbGpPWpGaD
Norethindrone—CYP3A7—Biological oxidations—GGT1—hepatitis B	0.000106	0.00444	CbGpPWpGaD
Norethindrone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000106	0.00444	CbGpPWpGaD
Norethindrone—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000105	0.00438	CbGpPWpGaD
Norethindrone—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	9.96e-05	0.00416	CbGpPWpGaD
Norethindrone—CYP3A5—Biological oxidations—CYP2A6—hepatitis B	9.84e-05	0.00411	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—HBE1—hepatitis B	9.55e-05	0.00399	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—F2—hepatitis B	9.12e-05	0.00381	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—IL10—hepatitis B	8.91e-05	0.00373	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—CD40LG—hepatitis B	8.91e-05	0.00373	CbGpPWpGaD
Norethindrone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	8.61e-05	0.0036	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—IFNG—hepatitis B	8.49e-05	0.00355	CbGpPWpGaD
Norethindrone—PGR—Signaling by ERBB4—CDKN1A—hepatitis B	8.38e-05	0.0035	CbGpPWpGaD
Norethindrone—PGR—Signaling by ERBB4—PTEN—hepatitis B	8.36e-05	0.00349	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—FASLG—hepatitis B	8.29e-05	0.00346	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—NR0B2—hepatitis B	8.07e-05	0.00337	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—FAS—hepatitis B	7.99e-05	0.00334	CbGpPWpGaD
Norethindrone—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	7.89e-05	0.0033	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—HLA-A—hepatitis B	7.86e-05	0.00328	CbGpPWpGaD
Norethindrone—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	7.77e-05	0.00325	CbGpPWpGaD
Norethindrone—CYP3A5—Biological oxidations—GGT1—hepatitis B	7.68e-05	0.00321	CbGpPWpGaD
Norethindrone—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	7.61e-05	0.00318	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—GGT2—hepatitis B	7.55e-05	0.00315	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	7.26e-05	0.00303	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—F2—hepatitis B	7.24e-05	0.00303	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	7.18e-05	0.003	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—NFKB1—hepatitis B	7.06e-05	0.00295	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—IFNG—hepatitis B	6.91e-05	0.00289	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SAG—hepatitis B	6.51e-05	0.00272	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—RIT2—hepatitis B	6.51e-05	0.00272	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	6.41e-05	0.00268	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—IL2—hepatitis B	6.14e-05	0.00257	CbGpPWpGaD
Norethindrone—CYP2C19—Biological oxidations—GGT1—hepatitis B	5.94e-05	0.00248	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—NFKB1—hepatitis B	5.75e-05	0.0024	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	5.6e-05	0.00234	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—HNF4A—hepatitis B	5.59e-05	0.00234	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—TNF—hepatitis B	5.5e-05	0.0023	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—IFNG—hepatitis B	5.49e-05	0.00229	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—IFNG—hepatitis B	5.24e-05	0.00219	CbGpPWpGaD
Norethindrone—PGR—Signaling by ERBB4—IL6—hepatitis B	5.22e-05	0.00218	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	5.03e-05	0.0021	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—IL2—hepatitis B	4.66e-05	0.00195	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	4.57e-05	0.00191	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—NFKB1—hepatitis B	4.57e-05	0.00191	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—TNF—hepatitis B	4.47e-05	0.00187	CbGpPWpGaD
Norethindrone—ALB—Vitamin B12 Metabolism—IL6—hepatitis B	4.43e-05	0.00185	CbGpPWpGaD
Norethindrone—ALB—Platelet degranulation—TGFB1—hepatitis B	4.11e-05	0.00172	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	4.09e-05	0.00171	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AKR1B1—hepatitis B	4.01e-05	0.00167	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	3.94e-05	0.00165	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—TP53—hepatitis B	3.94e-05	0.00165	CbGpPWpGaD
Norethindrone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	3.91e-05	0.00163	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GGT2—hepatitis B	3.84e-05	0.00161	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—TGFB1—hepatitis B	3.63e-05	0.00152	CbGpPWpGaD
Norethindrone—ALB—Folate Metabolism—IL6—hepatitis B	3.61e-05	0.00151	CbGpPWpGaD
Norethindrone—CYP3A4—Biological oxidations—GGT1—hepatitis B	3.57e-05	0.00149	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—TNF—hepatitis B	3.55e-05	0.00148	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—F2—hepatitis B	3.47e-05	0.00145	CbGpPWpGaD
Norethindrone—ABCB1—Allograft Rejection—TNF—hepatitis B	3.39e-05	0.00142	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—HSPA5—hepatitis B	3.31e-05	0.00138	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IFNB1—hepatitis B	2.98e-05	0.00125	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IFNA1—hepatitis B	2.91e-05	0.00122	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AKR1B1—hepatitis B	2.9e-05	0.00121	CbGpPWpGaD
Norethindrone—ALB—Selenium Micronutrient Network—IL6—hepatitis B	2.87e-05	0.0012	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GGT2—hepatitis B	2.78e-05	0.00116	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IFNA2—hepatitis B	2.71e-05	0.00113	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CXCL10—hepatitis B	2.57e-05	0.00107	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.54e-05	0.00106	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AKR1B1—hepatitis B	2.49e-05	0.00104	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GGT2—hepatitis B	2.39e-05	0.000999	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	2.33e-05	0.000976	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP2A6—hepatitis B	2.33e-05	0.000973	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	2.28e-05	0.000953	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AKR1B1—hepatitis B	2.24e-05	0.000936	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	2.22e-05	0.000927	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AKR1B1—hepatitis B	2.19e-05	0.000913	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	2.17e-05	0.000906	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	2.16e-05	0.000904	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	2.15e-05	0.000899	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GGT2—hepatitis B	2.15e-05	0.000897	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GOT2—hepatitis B	2.1e-05	0.00088	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GGT2—hepatitis B	2.1e-05	0.000876	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCR5—hepatitis B	1.99e-05	0.000832	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	1.82e-05	0.000761	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GGT1—hepatitis B	1.82e-05	0.000759	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GOT1—hepatitis B	1.82e-05	0.000759	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	1.79e-05	0.000749	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—F2—hepatitis B	1.79e-05	0.000747	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—NOS2—hepatitis B	1.77e-05	0.000738	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—F2—hepatitis B	1.71e-05	0.000714	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP2A6—hepatitis B	1.68e-05	0.000703	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	1.67e-05	0.0007	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GOT2—hepatitis B	1.52e-05	0.000636	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	1.48e-05	0.000617	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP2A6—hepatitis B	1.45e-05	0.000605	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKR1B1—hepatitis B	1.35e-05	0.000563	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GGT1—hepatitis B	1.31e-05	0.000549	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GOT1—hepatitis B	1.31e-05	0.000549	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GOT2—hepatitis B	1.31e-05	0.000548	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP2A6—hepatitis B	1.3e-05	0.000544	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GGT2—hepatitis B	1.29e-05	0.000539	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP2A6—hepatitis B	1.27e-05	0.000531	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	1.21e-05	0.000507	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IL2—hepatitis B	1.2e-05	0.000503	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GOT2—hepatitis B	1.18e-05	0.000492	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL2—hepatitis B	1.15e-05	0.000481	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GOT2—hepatitis B	1.15e-05	0.00048	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GOT1—hepatitis B	1.13e-05	0.000473	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GGT1—hepatitis B	1.13e-05	0.000473	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	1.13e-05	0.00047	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CTNNB1—hepatitis B	1.11e-05	0.000464	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1A—hepatitis B	1.09e-05	0.000454	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PTEN—hepatitis B	1.08e-05	0.000453	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NFKB1—hepatitis B	1.08e-05	0.00045	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.03e-05	0.000431	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GGT1—hepatitis B	1.02e-05	0.000424	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GOT1—hepatitis B	1.02e-05	0.000424	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GGT1—hepatitis B	9.91e-06	0.000414	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GOT1—hepatitis B	9.91e-06	0.000414	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ALB—hepatitis B	9.66e-06	0.000404	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TGFB1—hepatitis B	9.39e-06	0.000392	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	9.25e-06	0.000387	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TGFB1—hepatitis B	8.98e-06	0.000375	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP2A6—hepatitis B	7.82e-06	0.000327	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TP53—hepatitis B	7.73e-06	0.000323	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TP53—hepatitis B	7.39e-06	0.000309	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTEN—hepatitis B	7.37e-06	0.000308	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GOT2—hepatitis B	7.07e-06	0.000296	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALB—hepatitis B	6.99e-06	0.000292	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—hepatitis B	6.77e-06	0.000283	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GOT1—hepatitis B	6.11e-06	0.000255	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GGT1—hepatitis B	6.11e-06	0.000255	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALB—hepatitis B	5.4e-06	0.000226	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTEN—hepatitis B	5.33e-06	0.000223	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALB—hepatitis B	5.27e-06	0.00022	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTEN—hepatitis B	4.59e-06	0.000192	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTEN—hepatitis B	4.12e-06	0.000172	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTEN—hepatitis B	4.02e-06	0.000168	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALB—hepatitis B	3.25e-06	0.000136	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTEN—hepatitis B	2.48e-06	0.000104	CbGpPWpGaD
